Literature DB >> 33188619

Protective Activity of Aβ on Cell Cultures (PC12 and THP-1 after Differentiation) Preincubated with Lipopolysaccharide (LPS).

Benita Wiatrak1,2, Katarzyna Balon3.   

Abstract

Amyloid-β (Aβ), the influence of which is considered the pathomechanism of Alzheimer's disease, is also present in healthy people. The microbiome's impact is also taken into account, where bacterial lipopolysaccharide (LPS) activates inflammatory processes and stimulates microglia via TLRs. Molecules of bacterial origin can co-create senile plaques with Aβ. This study evaluated the activity of physiological Aβ concentrations on neuronal and microglial cells after preincubation with LPS. Two cell lines were used in the study: PC12 cells differentiated with NGF and THP-1 cells differentiated with phorbol 12-myristate 13-acetate (PMA). Cells were incubated with LPS at concentrations of 1-100 μM for 24 h and then with Aβ25-35 at a concentration of 0.001 μM or 1.0 μM for another 24 h. The viability of the culture and free oxygen radicals and the number of DNA strand breaks in both cell lines were evaluated. Additionally, for PC12 cells, neural features were assessed. Stimulation of repair processes in the presence of Aβ was observed for both studied cell lines. There was a decrease in free radical level and DNA damage number compared to control cultures (cells treated with LPS and without Aβ). The neurotrophic activity of Aβ was observed-the effect on neurites' growth even after the preincubation of PC12 cells with LPS. At the lowest concentration of LPS used, the increase in neurite length was about 50% greater than in the negative control. At low concentrations, Aβ has a protective effect on neuron-like PC12 cells pretreated with LPS.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-β; DNA damage; Lipopolysaccharide; ROS

Mesh:

Substances:

Year:  2020        PMID: 33188619      PMCID: PMC7932962          DOI: 10.1007/s12035-020-02204-w

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  67 in total

1.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 2.  Microbial amyloids--functions and interactions within the host.

Authors:  Kelly Schwartz; Blaise R Boles
Journal:  Curr Opin Microbiol       Date:  2013-01-09       Impact factor: 7.934

3.  Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease.

Authors:  Deepak Kumar Vijaya Kumar; Se Hoon Choi; Kevin J Washicosky; William A Eimer; Stephanie Tucker; Jessica Ghofrani; Aaron Lefkowitz; Gawain McColl; Lee E Goldstein; Rudolph E Tanzi; Robert D Moir
Journal:  Sci Transl Med       Date:  2016-05-25       Impact factor: 17.956

Review 4.  The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.

Authors:  Myles R Minter; Juliet M Taylor; Peter J Crack
Journal:  J Neurochem       Date:  2015-11-18       Impact factor: 5.372

Review 5.  Human gut microbiota: the links with dementia development.

Authors:  Rashad Alkasir; Jing Li; Xudong Li; Miao Jin; Baoli Zhu
Journal:  Protein Cell       Date:  2016-11-19       Impact factor: 14.870

Review 6.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

7.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

Review 8.  The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.

Authors:  Marta Sochocka; Katarzyna Donskow-Łysoniewska; Breno Satler Diniz; Donata Kurpas; Ewa Brzozowska; Jerzy Leszek
Journal:  Mol Neurobiol       Date:  2018-06-23       Impact factor: 5.590

9.  Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan.

Authors:  Naoki Saji; Shumpei Niida; Kenta Murotani; Takayoshi Hisada; Tsuyoshi Tsuduki; Taiki Sugimoto; Ai Kimura; Kenji Toba; Takashi Sakurai
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

Review 10.  Brain-Gut-Microbiota Axis in Alzheimer's Disease.

Authors:  Karol Kowalski; Agata Mulak
Journal:  J Neurogastroenterol Motil       Date:  2019-01-31       Impact factor: 4.924

View more
  5 in total

1.  Impact of NMDA receptor activation on DNA damage in PC12 neuron-like cell cultures in the presence of β-amyloid peptides.

Authors:  Benita Wiatrak; Przemysław Mieszała; Kazimierz Gąsiorowski
Journal:  Mol Biol Rep       Date:  2022-09-15       Impact factor: 2.742

2.  Ischemic Brain Neurodegeneration.

Authors:  Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

3.  Influence of 40 Hz and 100 Hz Vibration on SH-SY5Y Cells Growth and Differentiation-A Preliminary Study.

Authors:  Patrycja Grosman-Dziewiszek; Benita Wiatrak; Wojciech Dziewiszek; Paulina Jawień; Remigiusz Mydlikowski; Romuald Bolejko; Marta Szandruk-Bender; Ewa Karuga-Kuźniewska; Adam Szeląg
Journal:  Molecules       Date:  2022-05-23       Impact factor: 4.927

Review 4.  The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease.

Authors:  Benita Wiatrak; Katarzyna Balon; Paulina Jawień; Dominika Bednarz; Izabela Jęśkowiak; Adam Szeląg
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 5.  Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.

Authors:  Hyomin Jeong; Heewon Shin; Seungpyo Hong; YoungSoo Kim
Journal:  Exp Neurobiol       Date:  2022-04-30       Impact factor: 3.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.